Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Manson

Showing results (51-60 of 305) with videos related to

Pageof 31
Sort By:
JAMA|December 15, 1993
Body weight and mortality. A 27-year follow-up of middle-aged menI M Lee, J E Manson, C H Hennekens, et al.
British Journal of Cancer|March 5, 2002
Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level?I-M Lee, N R Cook, J E Manson, et al.
Current Opinion in Lipidology|March 30, 1999
Beta-carotene supplementation: a good thing, a bad thing, or nothing?W G Christen, J E Buring, J E Manson, et al.
Journal of the American College of Nutrition|August 1, 1993
Antioxidants and cardiovascular disease: a reviewJ E Manson, J M Gaziano, M A Jonas, et al.
JAMA|January 16, 1987
Body weight and longevity. A reassessmentJ E Manson, M J Stampfer, C H Hennekens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trialsN Keum, D H Lee, D C Greenwood, et al.
British Journal of Cancer|June 8, 2022
Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trialsN Keum, Q-Y Chen, D H Lee, et al.
The New England Journal of Medicine|June 29, 1995
The primary prevention of coronary heart disease in womenJ W Rich-Edwards, J E Manson, C H Hennekens, et al.
JAMA|September 24, 1999
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trialS Liu, U Ajani, C Chae, et al.
JAMA|July 24, 2001
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusA D Pradhan, J E Manson, N Rifai, et al.
Pageof 31

Showing results (51-60 of 305) with videos related to

Sort By:
Pageof 31
JAMA|December 15, 1993
Body weight and mortality. A 27-year follow-up of middle-aged menI M Lee, J E Manson, C H Hennekens, et al.
British Journal of Cancer|March 5, 2002
Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level?I-M Lee, N R Cook, J E Manson, et al.
Current Opinion in Lipidology|March 30, 1999
Beta-carotene supplementation: a good thing, a bad thing, or nothing?W G Christen, J E Buring, J E Manson, et al.
Journal of the American College of Nutrition|August 1, 1993
Antioxidants and cardiovascular disease: a reviewJ E Manson, J M Gaziano, M A Jonas, et al.
JAMA|January 16, 1987
Body weight and longevity. A reassessmentJ E Manson, M J Stampfer, C H Hennekens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trialsN Keum, D H Lee, D C Greenwood, et al.
British Journal of Cancer|June 8, 2022
Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trialsN Keum, Q-Y Chen, D H Lee, et al.
The New England Journal of Medicine|June 29, 1995
The primary prevention of coronary heart disease in womenJ W Rich-Edwards, J E Manson, C H Hennekens, et al.
JAMA|September 24, 1999
Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trialS Liu, U Ajani, C Chae, et al.
JAMA|July 24, 2001
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusA D Pradhan, J E Manson, N Rifai, et al.
Pageof 31